8,839
Total Claims
$1.4M
Drug Cost
1,302
Beneficiaries
$1,045
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-31%
Cost per patient vs peers
$1,045 vs $1,524 avg
-8%
Brand preference vs peers
12.5% vs 13.7% avg
Brand vs Generic
88% generic
Brand: 1,108 claims · $1.2M
Generic: 7,731 claims · $196K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 529 | $563K |
| Sacubitril/Valsartan | 130 | $177K |
| Rivaroxaban | 98 | $127K |
| Dronedarone Hcl | 52 | $84K |
| Evolocumab | 62 | $75K |
| Alirocumab | 39 | $33K |
| Ticagrelor | 23 | $29K |
| Pitavastatin Calcium | 28 | $20K |
| Metoprolol Succinate | 754 | $16K |
| Ezetimibe | 579 | $16K |
| Flecainide Acetate | 249 | $16K |
| Atorvastatin Calcium | 1,039 | $13K |
| Olmesartan Medoxomil | 369 | $9,848 |
| Icosapent Ethyl | 16 | $9,524 |
| Evolocumab | 12 | $8,430 |
Prescribing Profile
64
Unique Drugs
$867K
Patient Profile
75
Avg Age
50%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data